PDCD2L anticorps (N-Term)
Aperçu rapide pour PDCD2L anticorps (N-Term) (ABIN928432)
Antigène
Voir toutes PDCD2L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- PDCD2 L antibody was raised in rabbit using the N terminal of PDCD2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PDCD2L Blocking Peptide, (ABIN938223), is also available for use as a blocking control in assays to test for specificity of this PDCD2L antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PDCD2L (Programmed Cell Death 2-Like (PDCD2L))
-
Autre désignation
- PDCD2L
-
Sujet
- Over expression of PDCD2L attenutates TNF-alpha release in Daudi cells. PDCD2L over-expression restrained proliferation of HEK293T cells. DNA/flow cytometry analysis showed that the over-expression of PDCD2L severely delays cell cycle progression at S phase. These all suggest that PDCD2L might play a role in apoptosis. Synonyms: Polyclonal PDCD2L antibody, Anti-PDCD2L antibody, programmed cell death 2-like antibody, MGC13096 antibody.
Antigène
-